Allison Jackson, PA
Physician Assistant · Greenwell Springs, LANPI 1063489003
Payments from drug & device makers
Across 170 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$603
- Lilly USA, LLC$362
- Abbott$238
- Takeda Pharmaceuticals U.S.A., Inc.$185
- Antares Pharma, Inc.$134
- AbbVie$133
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,770100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $603 |
| Lilly USA, LLC | 27 | $362 |
| Abbott | 13 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $185 |
| Antares Pharma, Inc. | 7 | $134 |
| AbbVie | 8 | $133 |
| Merck | 8 | $127 |
| Boehringer Ingelheim | 7 | $115 |
| GSK | 6 | $103 |
| Sanofi-aventis U.S. LLC | 7 | $102 |
| Pfizer | 6 | $99 |
| Johnson & Johnson | 5 | $75 |
| Dexcom, Inc. | 2 | $71 |
| Phathom Pharmaceuticals, Inc. | 5 | $58 |
| Adlon Therapeutics L.p. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Corium, LLC | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| Tris Pharma Inc | 1 | $28 |
| Acerus Pharmaceuticals Corporation | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Genentech USA, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Amgen | 1 | $11 |
| Dynavax Technologies Corporation | 1 | $10 |
How this compares
$2,770 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 125 | $138,364 |
| JardianceEmpagliflozin | 107 | $109,192 |
| MounjaroTirzepatide | 43 | $43,419 |
| JanuviaSitagliptin Phosphate | 45 | $38,513 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $24,533 |
| RybelsusSemaglutide | 24 | $22,131 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $21,609 |
| FarxigaDapagliflozin Propanediol | 16 | $12,966 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $5,187 |
| PremarinEstrogens, Conjugated | 15 | $3,323 |
| Atorvastatin Calcium | 273 | $2,827 |
| Colestipol Hcl | 22 | $2,249 |
| Rosuvastatin Calcium | 181 | $1,887 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $1,884 |
| SynthroidLevothyroxine Sodium | 28 | $1,881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $603 | $160,495149 claims |
| Boehringer IngelheimJardiance | $115 | $109,192107 claims |
| Lilly USA, LLCMounjaro | $362 | $43,41943 claims |
| MerckJanuvia | $127 | $38,51345 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $102 | $21,60918 claims |
| PfizerPremarin | $99 | $3,32315 claims |
| AbbVieSynthroid | $133 | $1,88128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Greenwell Springs
- Shelly EsnardBaton Rouge$141K
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Claire DarreJefferson$50K
- Elizabeth ClementNew Orleans$35K
- Mary Negrotto GuntherSlidell$29K
- Kristen HebertZachary$27K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Savannah SanchezBaton Rouge$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.